Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/303% below fair value
$18.54+0.27 (+1.48%)
Close on Nov 18, 2026Market cap $903.94MP/E –Yield –
Artivion operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Artivion's operating income for the twelve months ending Jun 30, 2026 was $20.64M, up 17.4% year over year. For fiscal 2025 it was $33.75M, down 13.2% from the year before. Over ten years it grew 20.2% a year on average. The highest annual figure on record is $38.87M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.75M | -13.2% |
| FY2024 | Dec 31, 2024 | $38.87M | +577.0% |
| FY2023 | Dec 31, 2023 | $5.74M | -7.4% |
| FY2022 | Dec 31, 2022 | $6.20M | -23.6% |
| FY2021 | Dec 31, 2021 | $8.12M | +232.5% |
| FY2020 | Dec 31, 2020 | $2.44M | -85.7% |
| FY2019 | Dec 31, 2019 | $17.04M | +83.0% |
| FY2018 | Dec 31, 2018 | $9.31M | +16.8% |
| FY2017 | Dec 31, 2017 | $7.97M | -63.5% |
| FY2016 | Dec 31, 2016 | $21.82M | +307.5% |
| FY2015 | Dec 31, 2015 | $5.35M | -39.4% |
| FY2014 | Dec 31, 2014 | $8.84M | -36.0% |
| FY2013 | Dec 31, 2013 | $13.82M | +9.6% |
| FY2012 | Dec 31, 2012 | $12.61M | +8.3% |
| FY2011 | Dec 31, 2011 | $11.64M | +18.0% |
| FY2010 | Dec 31, 2010 | $9.87M | -31.9% |
| FY2009 | Dec 31, 2009 | $14.50M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.36M | -199.8% |
| Q1 FY2026 | Mar 31, 2026 | $5.79M | +169.8% |
| Q4 FY2025 | Dec 31, 2025 | $10.68M | +300.1% |
| Q3 FY2025 | Sep 30, 2025 | $12.54M | +185.8% |
| Q2 FY2025 | Jun 30, 2025 | $8.38M | +28.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.15M | -91.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.67M | -15.9% |
| Q3 FY2024 | Sep 30, 2024 | $4.39M | – |
| Q2 FY2024 | Jun 30, 2024 | $6.51M | -15.2% |
| Q1 FY2024 | Mar 31, 2024 | $25.31M | – |
| Q4 FY2023 | Dec 31, 2023 | $3.17M | -23.2% |
| Q3 FY2023 | Sep 30, 2023 | -$1.24M | – |
| Q2 FY2023 | Jun 30, 2023 | $7.68M | +69.0% |
| Q1 FY2023 | Mar 31, 2023 | -$3.86M | -336.0% |
| Q4 FY2022 | Dec 31, 2022 | $4.13M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.11M | -128.0% |
| Q2 FY2022 | Jun 30, 2022 | $4.54M | +243.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.64M | +13.1% |
| Q4 FY2021 | Dec 31, 2021 | -$9.34M | -587.9% |
| Q3 FY2021 | Sep 30, 2021 | $14.69M | +304.2% |
| Q2 FY2021 | Jun 30, 2021 | $1.32M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.45M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.91M | -47.3% |
| Q3 FY2020 | Sep 30, 2020 | $3.63M | -22.7% |
| Q2 FY2020 | Jun 30, 2020 | -$1.92M | -129.5% |
| Q1 FY2020 | Mar 31, 2020 | -$1.19M | -153.8% |
| Q4 FY2019 | Dec 31, 2019 | $3.63M | +30.7% |
| Q3 FY2019 | Sep 30, 2019 | $4.70M | +1.9% |
| Q2 FY2019 | Jun 30, 2019 | $6.50M | +20.3% |
| Q1 FY2019 | Mar 31, 2019 | $2.21M | – |
| Q4 FY2018 | Dec 31, 2018 | $2.78M | – |
| Q3 FY2018 | Sep 30, 2018 | $4.62M | +457.1% |
| Q2 FY2018 | Jun 30, 2018 | $5.41M | +12.9% |
| Q1 FY2018 | Mar 31, 2018 | -$3.49M | -237.0% |
| Q4 FY2017 | Dec 31, 2017 | -$195.00K | -103.8% |
| Q3 FY2017 | Sep 30, 2017 | $829.00K | -84.9% |
| Q2 FY2017 | Jun 30, 2017 | $4.79M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.55M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.11M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.48M | – |
See a number that looks wrong?